Skip to main content
Clinical Trials/IRCT20231107059983N1
IRCT20231107059983N1
Recruiting
Phase 3

Evaluation of the effect of intravenous lidocaine compared to topical lidocaine in patients who are candidates for esophagogastroduodenoscopy

Bandare-abbas University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Patients who are candidates for esophagogastroduodenoscopy.
Sponsor
Bandare-abbas University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Bandare-abbas University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • 18 to 65 year\-old patients candidate for Esophagogastroduodenoscopy
  • ASA class I or II

Exclusion Criteria

  • Age\<18 y/o or age \>65y/o
  • ASA class III or more
  • Sensitivity to lidocaine
  • Emergent patients
  • Patient dissatisfaction

Outcomes

Primary Outcomes

Not specified

Similar Trials